Uranium Royalty Corp. UROY
4.14
(0.11)
(2.59%)
as of 25 Sep
- Market cap
- $1.6B
- P/E
- 10.8×
Follow UROY
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 255.93 | 13.51 | 8.84 |
P/S ratio |
23.69 | 16.17 | 2.90 | 2.49 | |
P/FCF ratio |
30.36 | 22.93 | 3.05 | 2.58 | |
P/Operating CF |
(226.49) | 108.83 | 3.56 | 10.08 | |
P/B ratio |
2.75 | 2.33 | 1.73 | 0.49 | |
Price to Tangible BV |
3.20 | 2.66 | 1.94 | 0.50 | |
EV/Sales |
21.80 | 13.82 | 1.36 | 4.72 | |
EV/EBITDA |
0.00 | 381.77 | 5.26 | 16.13 | |
EV/Operating CF |
27.17 | 18.97 | 1.43 | 4.86 | |
EV/FCF |
27.94 | 19.61 | 1.43 | 4.88 | |
Quick Ratio |
80.41 | 139.32 | 5.31 | 0.86 | |
Current Ratio |
265.75 | 325.30 | 5.94 | 0.88 | |
Net Debt/EBITDA |
25.99 | (46.74) | (6.36) | 28.82 | |
Debt/Assets |
0.04% | 0.03% | 0.02% | 31.01% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.54 | |
Asset Turnover |
0.12 | 0.16 | 0.63 | 0.20 | |
Operating CF/Net income |
(1.95) | 4.16 | 4.19 | 3.26 | |
Capex/Depreciation |
0.26 | (0.02) | (1.09) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6,391.53% | 7.82% | 0.75% | 1.87% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
1,084.41% | 1.61% | 0.11% | 0.15% | |
Graham Net Nets |
0.30 | 0.36 | 0.50 | (1.31) | |
Graham Number |
0.00 | 0.88 | 3.82 | 7.76 | |
Earnings Yield |
(0.05%) | 0.39% | 7.40% | 11.31% | |
Free Cash Flow Yield |
3.29% | 4.36% | 32.79% | 38.83% | |
Revenue per Share |
0.00 | 0.09 | 1.08 | 0.33 | |
Operating CF per Share |
(0.02) | 0.04 | 1.09 | 0.34 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.02) | 0.04 | 1.09 | 0.34 | |
Cash per Share |
0.44 | 0.71 | 2.12 | 0.73 | |
Shareholders Equity per Share |
1.77 | 1.94 | 2.25 | 6.96 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.77 | 1.94 | 2.25 | 6.96 | |
Free Cash Flow |
(2.88) | 5.88 | 152.03 | 52.97 | |
Working Capital |
195.71 | 233.17 | 273.82 | (17.25) | |
Capital Expenditures |
0.01 | 0.00 | (0.01) | — | |
Net Current Asset Value |
195.62 | 232.88 | 268.75 | (698.72) | |
EV/EBIT |
0.00 | 409.13 | 5.27 | 16.20 | |
Capex to Sales |
(0.37) | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
5,018.98% | 11.78% | 24.12% | 31.44% | |
Price to Operating Income |
0.00 | 478.56 | 11.22 | 8.54 | |
| Other line items | |||||
Average Receivables |
5.14 | 0.02 | 0.05 | 2.11 | |
Average Payables |
0.84 | 0.71 | 1.41 | 16.25 | |
Average Inventory |
149.39 | 144.50 | 95.98 | 69.16 | |
Average Assets |
229.65 | 242.93 | 294.72 | 1,064.38 | |
Average Common Equity |
221.73 | 241.97 | 263.94 | 654.14 |
Columns are period end dates